newsfilter
← Latest News
GlobeNewswire·

Tenax Therapeutics Appoints Timothy Healey, MBA as Chief Commercial Officer

CHAPEL HILL, N.C., May 04, 2026 (GLOBE NEWSWIRE) -- Tenax Therapeutics, Inc. (NASDAQ:TENX) ("Tenax" or "Tenax Therapeutics" or the "Company"), a Phase 3, development-stage pharmaceutical company using clinical insights